CA1088865A - Compose pharmaceutique contenant un alkaloide hydrogene de l'ergot et de l'etilefrine - Google Patents
Compose pharmaceutique contenant un alkaloide hydrogene de l'ergot et de l'etilefrineInfo
- Publication number
- CA1088865A CA1088865A CA278,488A CA278488A CA1088865A CA 1088865 A CA1088865 A CA 1088865A CA 278488 A CA278488 A CA 278488A CA 1088865 A CA1088865 A CA 1088865A
- Authority
- CA
- Canada
- Prior art keywords
- etilefrin
- pharmaceutical composition
- formula
- compound
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP2621906.7 | 1976-05-17 | ||
| DE19762621906 DE2621906A1 (de) | 1976-05-17 | 1976-05-17 | Neue therapeutische mischung und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1088865A true CA1088865A (fr) | 1980-11-04 |
Family
ID=5978199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA278,488A Expired CA1088865A (fr) | 1976-05-17 | 1977-05-16 | Compose pharmaceutique contenant un alkaloide hydrogene de l'ergot et de l'etilefrine |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS52139730A (fr) |
| AT (1) | AT366574B (fr) |
| AU (1) | AU513718B2 (fr) |
| BE (1) | BE854694A (fr) |
| CA (1) | CA1088865A (fr) |
| CS (1) | CS207455B2 (fr) |
| DE (1) | DE2621906A1 (fr) |
| ES (1) | ES458819A1 (fr) |
| FR (1) | FR2351657A1 (fr) |
| GB (1) | GB1565447A (fr) |
| GR (1) | GR72995B (fr) |
| HK (1) | HK3283A (fr) |
| HU (1) | HU175167B (fr) |
| IE (1) | IE45197B1 (fr) |
| IL (1) | IL52101A (fr) |
| MY (1) | MY8400062A (fr) |
| NL (1) | NL177981C (fr) |
| NZ (1) | NZ184111A (fr) |
| PH (1) | PH20257A (fr) |
| PT (1) | PT66552B (fr) |
| SE (1) | SE425545B (fr) |
| ZA (1) | ZA772935B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935515A1 (de) * | 1979-09-03 | 1981-03-19 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Arzneipraeparat |
| JPH0227013U (fr) * | 1988-08-10 | 1990-02-22 | ||
| IL145550A0 (en) | 1999-03-26 | 2002-06-30 | Pozen Inc | High potency dihydroergotamine compositions |
-
1976
- 1976-05-17 DE DE19762621906 patent/DE2621906A1/de active Granted
-
1977
- 1977-05-09 SE SE7705340A patent/SE425545B/xx not_active IP Right Cessation
- 1977-05-12 FR FR7714507A patent/FR2351657A1/fr active Granted
- 1977-05-13 GB GB20210/77A patent/GB1565447A/en not_active Expired
- 1977-05-13 PH PH19768A patent/PH20257A/en unknown
- 1977-05-13 NL NLAANVRAGE7705306,A patent/NL177981C/xx not_active IP Right Cessation
- 1977-05-16 ES ES458819A patent/ES458819A1/es not_active Expired
- 1977-05-16 CA CA278,488A patent/CA1088865A/fr not_active Expired
- 1977-05-16 IE IE1001/77A patent/IE45197B1/en unknown
- 1977-05-16 CS CS773204A patent/CS207455B2/cs unknown
- 1977-05-16 BE BE177623A patent/BE854694A/fr not_active IP Right Cessation
- 1977-05-16 AT AT0347677A patent/AT366574B/de not_active IP Right Cessation
- 1977-05-16 NZ NZ184111A patent/NZ184111A/xx unknown
- 1977-05-16 HU HU77SA3035A patent/HU175167B/hu not_active IP Right Cessation
- 1977-05-16 PT PT66552A patent/PT66552B/pt unknown
- 1977-05-16 JP JP5624877A patent/JPS52139730A/ja active Granted
- 1977-05-16 IL IL52101A patent/IL52101A/xx unknown
- 1977-05-16 AU AU25169/77A patent/AU513718B2/en not_active Expired
- 1977-05-17 GR GR53485A patent/GR72995B/el unknown
- 1977-05-17 ZA ZA00772935A patent/ZA772935B/xx unknown
-
1983
- 1983-01-20 HK HK32/83A patent/HK3283A/xx unknown
-
1984
- 1984-12-30 MY MY62/84A patent/MY8400062A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1565447A (en) | 1980-04-23 |
| NZ184111A (en) | 1980-02-21 |
| JPS52139730A (en) | 1977-11-21 |
| IL52101A (en) | 1980-01-31 |
| ZA772935B (en) | 1979-01-31 |
| FR2351657A1 (fr) | 1977-12-16 |
| CS207455B2 (en) | 1981-07-31 |
| PT66552B (en) | 1979-09-03 |
| MY8400062A (en) | 1984-12-31 |
| IE45197B1 (en) | 1982-07-14 |
| SE7705340L (sv) | 1977-11-18 |
| NL177981C (nl) | 1986-01-02 |
| IE45197L (en) | 1977-11-17 |
| JPS628413B2 (fr) | 1987-02-23 |
| AU513718B2 (en) | 1980-12-18 |
| SE425545B (sv) | 1982-10-11 |
| HK3283A (en) | 1983-01-20 |
| DE2621906A1 (de) | 1977-12-01 |
| ES458819A1 (es) | 1978-08-01 |
| GR72995B (fr) | 1984-01-24 |
| NL177981B (nl) | 1985-08-01 |
| PH20257A (en) | 1986-11-14 |
| PT66552A (en) | 1977-06-01 |
| IL52101A0 (en) | 1977-07-31 |
| AT366574B (de) | 1982-04-26 |
| NL7705306A (nl) | 1977-11-21 |
| DE2621906C2 (fr) | 1988-04-21 |
| BE854694A (fr) | 1977-11-16 |
| ATA347677A (de) | 1981-09-15 |
| FR2351657B1 (fr) | 1980-01-18 |
| HU175167B (hu) | 1980-05-28 |
| AU2516977A (en) | 1978-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100516095B1 (ko) | 파킨슨 질환 치료용 지속방출형 정제 제제 | |
| JPH09503501A (ja) | 医薬組成物 | |
| US6191153B1 (en) | Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity | |
| EP1080091A1 (fr) | Nouvelles 1,3,8-triazaspiro[4.5]decanones possedant une affinite elevee pour les sous-types du recepteur opioide | |
| EP0774259A1 (fr) | Nouvelle utilisation des composés organiques | |
| EP0682947B1 (fr) | Médicament pour le traitement thérapeutique prophylactique des maladies causées par une hyperplasie des cellules musculaires lisses | |
| JPH10147524A (ja) | フォルスコリン誘導体含有経口製剤及び医薬製剤の製法 | |
| CA1088865A (fr) | Compose pharmaceutique contenant un alkaloide hydrogene de l'ergot et de l'etilefrine | |
| HU219482B (hu) | (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására | |
| KR920010388B1 (ko) | 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 약학제제의 제조방법 | |
| JPH02326B2 (fr) | ||
| JPH1192369A (ja) | 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用 | |
| WO1999020276A1 (fr) | Composition medicamenteuse stable | |
| US5069911A (en) | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions | |
| EP0379579A1 (fr) | Preparation pharmaceutique a liberation amelioree | |
| KR100352898B1 (ko) | 새로운3-벤조일-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제 | |
| JPS61249986A (ja) | キノリジン誘導体を含有する医薬組成物 | |
| JP2001519754A (ja) | ２−［２−（ジメチルアミノ）エチル］−８，８−ジプロピル−２−アザスピロ［４．５］デカンジマレイン酸塩 | |
| US6784315B2 (en) | Stilbene derivative crystal and method for producing the same | |
| EP0342396A1 (fr) | Onguents ophtalmologiques à base d'alcoloides peptidiques d'ergot pour le traitement du glaucome | |
| JPH03294270A (ja) | ヒダントイン誘導体を有効成分として含有する血糖低下剤 | |
| CA1328613C (fr) | Agent hypotensif contenant de la 4'-ethyl-2-methyl-3-piperidinopropiophenone | |
| US3947590A (en) | Compositions and methods of increasing renal blood flow with gamma-glutamyl amide of dopamine | |
| EP0704214B1 (fr) | Procédé de préparation de nizatidine pure | |
| EP0115331B1 (fr) | Médicament contre l'apoplexie cérébrale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |